問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
陳東藝
下載
2021-11-01 - 2022-08-29
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2023-04-13 - 2027-05-05
Participate Sites13Sites
Recruiting13Sites
2023-03-01 - 2027-02-28
Participate Sites17Sites
Recruiting17Sites
2021-05-18 - 2023-12-31
Heart Failure
AZD9977及Dapagliflozin
Participate Sites10Sites
Not yet recruiting5Sites
Recruiting5Sites
2018-10-24 - 2024-03-31
Obesity
Semaglutide B 3.0 mg/mL PDS290 or Semaglutide placebo
Recruiting4Sites
Terminated2Sites
Division of Cardiovascular Diseases
全部
